Global brain atrophy after unilateral parietal lesion and its prevention by erythropoietin
about
Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseasesErythropoietin dampens injury-induced microglial motility.Neuroprotective effects of ischemic preconditioning on global brain ischemia through up-regulation of acid-sensing ion channel 2aInhibition of bradykinin receptor B1 protects mice from focal brain injury by reducing blood-brain barrier leakage and inflammationA longitudinal VBM study monitoring treatment with erythropoietin in patients with Friedreich ataxiaSurvival and proliferative roles of erythropoietin beyond the erythroid lineage.Different expression patterns of Ngb and EPOR in the cerebral cortex and hippocampus revealed distinctive therapeutic effects of intranasal delivery of Neuro-EPO for ischemic insults to the gerbil brain.Deferoxamine inhibits microglial activation, attenuates blood-brain barrier disruption, rescues dendritic damage, and improves spatial memory in a mouse model of microhemorrhages.Blocking of bradykinin receptor B1 protects from focal closed head injury in mice by reducing axonal damage and astroglia activation.Optical imaging of cell death in traumatic brain injury using a heat shock protein-90 alkylator.Erythropoietin: a candidate treatment for mood symptoms and memory dysfunction in depression.Improvement of cognitive functions in chronic schizophrenic patients by recombinant human erythropoietin.Recombinant Human Erythropoietin: Novel Strategies for Neuroprotective/Neuro-regenerative Treatment of Multiple SclerosisLipoic acid and bone marrow derived cells therapy induce angiogenesis and cell proliferation after focal brain injury.Epo is involved in angiogenesis in human glioma.Exploring recombinant human erythropoietin in chronic progressive multiple sclerosis
P2860
Q28388335-D462B75D-D7F3-4694-945B-5CEB949F093DQ30660277-D1136293-E139-4CE0-B088-38B50698FA20Q33649207-CC87354A-B02D-4B27-9573-4B9465088721Q34171305-BE7AB0FA-061A-4F71-9876-FB9F76BCF737Q34285714-E1C1E3A2-5330-4A6D-A887-D0F457BF2D1EQ34725972-578C2B0B-D1D6-43E1-85BD-C008D54F903DQ35440761-F9444AEB-2061-4094-BC30-D12CD47F3175Q36014250-03682726-FBB3-4D86-8E6B-D3D53D3131C3Q36211340-8B292FCC-981A-4C33-8886-EA26299E4BAFQ36586529-E32577DA-57C9-4AB9-B677-F612952CD4FAQ37938732-26F1E76C-DED6-435B-B80F-CACA082AEF02Q38403090-56AD0223-6E43-4DFD-BA1F-6250920CBC45Q41173431-3DEC597C-3249-43D7-9B98-8963BA161768Q45036156-41C852D6-BFCB-472C-9FA0-EFE3B137D4E6Q48135959-43184A57-6FCD-46F8-820E-4B42BCE23B6AQ59264385-8414EAFA-E2FF-4D24-8AF5-C8822622F377
P2860
Global brain atrophy after unilateral parietal lesion and its prevention by erythropoietin
description
article
@en
im Dezember 2005 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в грудні 2005
@uk
name
Global brain atrophy after uni ...... s prevention by erythropoietin
@en
Global brain atrophy after uni ...... s prevention by erythropoietin
@nl
type
label
Global brain atrophy after uni ...... s prevention by erythropoietin
@en
Global brain atrophy after uni ...... s prevention by erythropoietin
@nl
prefLabel
Global brain atrophy after uni ...... s prevention by erythropoietin
@en
Global brain atrophy after uni ...... s prevention by erythropoietin
@nl
P2093
P50
P356
P1433
P1476
Global brain atrophy after uni ...... s prevention by erythropoietin
@en
P2093
Barbara Meyer
Claas-Christian Riechers
Daniel Kämmer
Derya Sargin
Konstantin Radyushkin
Oliver Natt
Swetlana Sperling
Thomas Michaelis
P304
P356
10.1093/BRAIN/AWH703
P407
P577
2005-12-09T00:00:00Z